-The Hindu The Genetic Engineering Approval Committee (GEAC) on Friday gave the green signal for field trials of genetically modified (GM) rice, mustard, cotton, chickpea and brinjal at its meeting in Delhi. Hem Kumar Pande, chairperson of the GEAC told The Hindu that meetings were not held for a year since March 2013 and there was a backlog of 70 applications pending since 2011-12 of which 60 have been cleared so far. Friday's...

-The Hindu   No one can attack India's well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law India and its intellectual property (IP) laws have been the subject of sharp criticism recently. Now, there is talk of the government invoking emergency provisions with regard to Dasatinib, a cancer drug. The decibel level may go up several notches. Let us look...

-Tehelka     Survival International is an NGO that works for the welfare of indigenous tribal populations all over the world. Recently, it launched the Proud, Not Primitive campaign in India. Survival’s press officer Alice bayer was in India to spread the word. Speaking to G Vishnu, she spells out what is wrong with the development versus tribal rights debate.  Edited Excerpts from an Interview * Tell us about the Proud, Not Primitive campaign? Government...

-The Times of India CHANDIGARH: The Congress government in Haryana will soon have to return crores of rupees to the Centre after the parliamentary standing committee on agriculture has found truth in IAS officer Ashok Khemka's allegations that farmer subsidies had been misappropriated. The committee, headed by CPM MP Basudeb Acharia, has 31 MPs, including Jyoti Mirdha, sister-in-law of Rohtak MP Deepender Hooda. Deepender is son of Haryana chief minister Bhupinder Hooda...

-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...